GCI Virtual Summit Thought Leader – Dr. David Bearman, American Academy of Cannabinoid Medicine

GCI Summit - David Bearman - American Academy of Cannabinoid Medicine - GCI Virtual Summit - Global Cannabis Intelligence

GCI Virtual Summit Thought Leader – Dr. David Bearman, American Academy of Cannabinoid Medicine

David participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.

Check out his bio below:

Dr. David Bearman has offered more than 45 years of experience in the following areas: Deputy Director for Health Policy and Grant Development in Medicaid County Organized Health System; Medical Director of Capitated Medicaid County Organized Health Care System; Director of Public Health Department and Health Officer; Student Health Service Director; Medical Director Community Clinic; Medical Director Methadone Maintenance Program; Director Drug Treatment Program; Project Director Substance Abuse Prevention Program; Primary Care Clinician; Private Practice Physician; Officer in U.S. Public Health Service, Vice-President Plasmaphoresis Center; Consultant; Lecturer and Author on: the endocannabinoid system, use of cannabis for treatment of ADD/ADHD, use of cannabis for treatment of PTSD, standards of care for recommending medicinal cannabis, drug policy reform, Health Care Organization; Managed Care; Utilization Review; Human Sexuality; and Drug Abuse Treatment and Prevention; Educator, Electronic Medical Record Implementor; Grant Writer; and Expert Witness.

If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.

You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.